CSNpharm
CSNpharm
GF109203X is a potent PKC inhibitor with IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ in cell-free assays, respectively, showing more than 3000-fold selectivity for PKC as compared to EGFR, PDGFR and insulin receptor.
More Information
Supplier Page
CSNpharm
GF109203X is a potent PKC inhibitor with IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ in cell-free assays, respectively, showing more than 3000-fold selectivity for PKC as compared to EGFR, PDGFR and insulin receptor.
More Information
Supplier Page
CSNpharm
Bisindolylmaleimide II is a potent, ATP-competitive protein kinase C (PKC) inhibitor with IC50 of 0.01 μM, and also a potent nAChR antagonist.
More Information
Supplier Page
CSNpharm
Bisindolylmaleimide II is a potent, ATP-competitive protein kinase C (PKC) inhibitor with IC50 of 0.01 μM, and also a potent nAChR antagonist.
More Information
Supplier Page
CSNpharm
Bisindolylmaleimide II is a potent, ATP-competitive protein kinase C (PKC) inhibitor with IC50 of 0.01 μM, and also a potent nAChR antagonist.
More Information
Supplier Page
CSNpharm
CSNpharm
Bisindolylmaleimide X hydrochloride (BIM-X hydrochloride) is a potent and selective protein kinase C (PKC) inhibitor. Bisindolylmaleimide X hydrochloride is a potent cyclin-dependent kinase 2 (CDK2) antagonist with an IC50 of 200 nM[1].
More Information
Supplier Page
CSNpharm
Bisindolylmaleimide X hydrochloride (BIM-X hydrochloride) is a potent and selective protein kinase C (PKC) inhibitor. Bisindolylmaleimide X hydrochloride is a potent cyclin-dependent kinase 2 (CDK2) antagonist with an IC50 of 200 nM[1].
More Information
Supplier Page
CSNpharm
Bisindolylmaleimide X hydrochloride (BIM-X hydrochloride) is a potent and selective protein kinase C (PKC) inhibitor. Bisindolylmaleimide X hydrochloride is a potent cyclin-dependent kinase 2 (CDK2) antagonist with an IC50 of 200 nM[1].
More Information
Supplier Page
CSNpharm
Bisindolylmaleimide X hydrochloride (BIM-X hydrochloride) is a potent and selective protein kinase C (PKC) inhibitor. Bisindolylmaleimide X hydrochloride is a potent cyclin-dependent kinase 2 (CDK2) antagonist with an IC50 of 200 nM[1].
More Information
Supplier Page
CSNpharm
Bisindolylmaleimide X hydrochloride (BIM-X hydrochloride) is a potent and selective protein kinase C (PKC) inhibitor. Bisindolylmaleimide X hydrochloride is a potent cyclin-dependent kinase 2 (CDK2) antagonist with an IC50 of 200 nM[1].
More Information
Supplier Page
CSNpharm
Bismuth subcitrate is an antibiotic used to treat stomach ulcers associated with Helicobacter pylori, a bacterial infection.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Bithionol is an anti-parasitic drug and can be used to inhibit solid tumor growth in several preclinical cancer models.
More Information
Supplier Page
CSNpharm
Bithionol sulfoxide is a clinically approved anti-parasitic drug and has been shown to inhibit solid tumor growth in several preclinical cancer models.
More Information
Supplier Page
CSNpharm
BIX-02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM, and does not inhibit closely related kinases MEK1, MEK2, ERK2, and JNK2.
More Information
Supplier Page
CSNpharm
BIX-02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM, and does not inhibit closely related kinases MEK1, MEK2, ERK2, and JNK2.
More Information
Supplier Page
CSNpharm
BIX-02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM, and does not inhibit closely related kinases MEK1, MEK2, ERK2, and JNK2.
More Information
Supplier Page
CSNpharm
BIX-02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM, and does not inhibit closely related kinases MEK1, MEK2, ERK2, and JNK2.
More Information
Supplier Page
CSNpharm
BIX-02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM, and does not inhibit closely related kinases MEK1, MEK2, ERK2, and JNK2.
More Information
Supplier Page
CSNpharm
BIX-02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM, and does not inhibit closely related kinases MEK1, MEK2, ERK2, and JNK2.
More Information
Supplier Page
CSNpharm
Bleomycin sulfate is a glycopeptide antitumor antibiotic produced by the bacterium S. verticillus. It functions by breaking single- and double-strand DNA in tumor cells and interrupts the cell cycle.
More Information
Supplier Page
CSNpharm
Bleomycin sulfate is a glycopeptide antitumor antibiotic produced by the bacterium S. verticillus. It functions by breaking single- and double-strand DNA in tumor cells and interrupts the cell cycle.
More Information
Supplier Page
CSNpharm
Bleomycin sulfate is a glycopeptide antitumor antibiotic produced by the bacterium S. verticillus. It functions by breaking single- and double-strand DNA in tumor cells and interrupts the cell cycle.
More Information
Supplier Page
CSNpharm
Bleomycin sulfate is a glycopeptide antitumor antibiotic produced by the bacterium S. verticillus. It functions by breaking single- and double-strand DNA in tumor cells and interrupts the cell cycle.
More Information
Supplier Page
CSNpharm
Bleomycin sulfate is a glycopeptide antitumor antibiotic produced by the bacterium S. verticillus. It functions by breaking single- and double-strand DNA in tumor cells and interrupts the cell cycle.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
BLT-1
10mg
| ≥98%
CSNpharm
BLT-1 is a specific inhibitor of the SR-BI (Scavenger receptor, class B, type I) mediated lipid transfer. The compound inhibits both cellular selective lipid uptake of HDL cholesteryl ether and efflux of cellular cholesterol to HDL.
More Information
Supplier Page
BLT-1
50mg
| ≥98%
CSNpharm
BLT-1 is a specific inhibitor of the SR-BI (Scavenger receptor, class B, type I) mediated lipid transfer. The compound inhibits both cellular selective lipid uptake of HDL cholesteryl ether and efflux of cellular cholesterol to HDL.
More Information
Supplier Page
BLT-1
100mg
| ≥98%
CSNpharm
BLT-1 is a specific inhibitor of the SR-BI (Scavenger receptor, class B, type I) mediated lipid transfer. The compound inhibits both cellular selective lipid uptake of HDL cholesteryl ether and efflux of cellular cholesterol to HDL.
More Information
Supplier Page
BLT-1
25mg
| ≥98%
CSNpharm
BLT-1 is a specific inhibitor of the SR-BI (Scavenger receptor, class B, type I) mediated lipid transfer. The compound inhibits both cellular selective lipid uptake of HDL cholesteryl ether and efflux of cellular cholesterol to HDL.
More Information
Supplier Page
CSNpharm
BLU-782 is a potent, selective ALK2 inhibitor that prevents edema and heterotopic bone formation in a FOP mouse model.
More Information
Supplier Page
CSNpharm
BLU-782 is a potent, selective ALK2 inhibitor that prevents edema and heterotopic bone formation in a FOP mouse model.
More Information
Supplier Page
CSNpharm
BLU-782 is a potent, selective ALK2 inhibitor that prevents edema and heterotopic bone formation in a FOP mouse model.
More Information
Supplier Page
CSNpharm
BLU-782 is a potent, selective ALK2 inhibitor that prevents edema and heterotopic bone formation in a FOP mouse model.
More Information
Supplier Page
BMPS
100mg
| ≥99%
CSNpharm
BMS-3
1mg
| ≥99%
CSNpharm
BMS-3
50mg
| ≥99%
CSNpharm
BMS-3
5mg
| ≥99%
CSNpharm
BMS-3
10mg
| ≥99%
CSNpharm
BMS-3
100mg
| ≥99%
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
BMS-309403 is an inhibitor of fatty acid binding protein 4 (FABP4) with Ki of less than 2 nM that decreases fatty acid uptake in adipocytes in vitro.
More Information
Supplier Page
